Definitely an interesting PR from the other day. This confirms the dilution, however, so far this has meant higher volume. This also confirms the increased revenue, just hope it continues, as this will be what keeps the pps up with the increased share count.
Perhaps the most interesting though is the article they linked about how stem cells have helped someone, and the other paper and write up on their website. I don't understand most of it, but it does seem like they are heading in the right direction.
With any luck, they will continue to grow and the trial on the next 6 patients will be just as successful and they can go back to officially reporting numbers again. Once this occurs, the pps should increase to a respectable valuation in line with other bio-techs.